|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9200 HKD | -.--% |
|
-3.16% | -14.02% |
| 06-17 | Regent Pacific's Senstend Approved in China | MT |
| 06-16 | Regent Pacific Group Limited Receives NMPA Approval For Senstend And Announces Commercialisation in China | CI |
| Market Cap | 34.24M 268M 29.76M 27.7M 25.43M 48.03M 3.27B 48.77M 327M 128M 1.63B 129M 126M 5.46B | P/E 2024 |
-2.39x | P/E 2025 | -7.63x |
|---|---|---|---|---|---|
| Enterprise Value | 38.02M 298M 33.05M 30.76M 28.24M 53.34M 3.63B 54.16M 363M 142M 1.81B 143M 140M 6.06B | EV / Sales 2024 |
19.4x | EV / Sales 2025 | 121x |
| Free-Float |
31.54% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -3.16% | ||
| 1 month | -11.54% | ||
| 3 months | +48.39% | ||
| 6 months | -8.00% | ||
| Current year | -14.02% |
| 1 week | 0.9 |  | 0.95 |
| 1 month | 0.86 | | 1.03 |
| Current year | 0.57 | | 1.22 |
| 1 year | 0.57 | | 1.22 |
| 3 years | 0.32 | | 1.28 |
| 5 years | 0.25 | | 4.06 |
| 10 years | 0.25 | | 15.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jamie Gibson
CEO | Chief Executive Officer | 60 | 2002-04-30 |
Yui Fui Wong
DFI | Director of Finance/CFO | 51 | 2010-12-31 |
Michael Wyllie
CTO | Chief Tech/Sci/R&D Officer | 75 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jamie Gibson
BRD | Director/Board Member | 60 | 2001-12-31 |
| Director/Board Member | 62 | 2000-05-31 | |
Jim Mellon
CHM | Chairman | 70 | 1993-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/5/23 | Other | Director | 3,639,574 | 0.1517% | ||
| 6/5/23 | Other | Founder | 2,455,657,694 | 102.3438% | ||
| 6/5/23 | Other | Chief Executive Officer | 149,249,568 | 6.2202% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -3.16% | -3.16% | -2.13% | 34.24M | |
| -0.53% | -3.95% | +50.70% | +153.56% | 1,024B | |
| +0.21% | -2.68% | +53.20% | +51.79% | 618B | |
| -2.51% | -3.25% | +28.54% | +68.94% | 443B | |
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | |
| -0.69% | -0.30% | +13.76% | +12.83% | 264B | |
| -7.37% | -4.40% | -0.74% | -44.28% | 209B | |
| -0.64% | +2.43% | +29.74% | +65.93% | 208B | |
| -0.82% | +0.70% | +15.05% | +72.05% | 162B | |
| +0.40% | +1.92% | +6.47% | -29.77% | 143B | |
| Average | -1.19% | -1.41% | +23.11% | +37.96% | 341.89B | |
| Weighted average by Cap. | -1.00% | -2.02% | +36.14% | +71.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 719K 5.64M 625K 582K 534K 1.01M 68.64M 1.02M 6.86M 2.69M 34.17M 2.7M 2.64M 115M | 363K 2.85M 316K 294K 270K 509K 34.65M 517K 3.46M 1.36M 17.25M 1.36M 1.33M 57.85M |
| Net income | -4.48M -35.15M -3.9M -3.63M -3.33M -6.29M -428M -6.39M -42.75M -16.78M -213M -16.83M -16.46M -714M | -4.71M -36.93M -4.09M -3.81M -3.5M -6.61M -450M -6.71M -44.92M -17.63M -224M -17.69M -17.3M -751M |
| Net Debt | 3.22M 25.23M 2.8M 2.6M 2.39M 4.51M 307M 4.58M 30.68M 12.04M 153M 12.08M 11.82M 513M | 3.78M 29.66M 3.29M 3.06M 2.81M 5.31M 361M 5.39M 36.08M 14.16M 180M 14.21M 13.9M 603M |
Employees
16
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | HK$0.9200 | -.--% | 0 |
| 26-07-30 | HK$0.9200 | -.--% | 50,000 |
| 26-07-29 | HK$0.9200 | -.--% | 15,000 |
| 26-07-28 | HK$0.9200 | -3.16% | 80,000 |
| 26-07-27 | HK$0.9500 | -.--% | 1,000 |
- Stock Market
- Stocks
- 575 Stock
Select your edition
All financial news and data tailored to specific country editions
